Seoul – October 12, 2026 -- South Korea's GCCL and LabConnect signed a memorandum of understanding on October 12 to link their North American and Asia-Pacific (APAC) central laboratory capabilities for joint sales and project execution in global clinical trials.

Partners formalize a relationship spanning more than 20 years

The agreement builds on a collaboration that has run for more than 20 years. It aims to improve the operational efficiency of global trial projects by combining each company's regional expertise. Financial terms were not disclosed.